Antiviral Drugs Market - By Drug Class (DNA Polymerase Inhibitors, Reverse Transcriptase Inhibitors, Protease Inhibitors, Neuraminidase Inhibitors), By Indication (Influenza, HIV AIDS, Hepatitis, Coronavirus Infection), By Type, By Age Group & Forecast, 2022-2028
Report ID: GMI4968
Selected License: | $4850 |
Discount: | $728 |
Call us or write to us: